1. Sex, racial/ethnic and socioeconomic disparities in patients with metastatic bone disease.
- Author
-
Jawad MU, Pollock BH, Wise BL, Zeitlinger LN, O' Donnell EF, Carr-Ascher JR, Cizik A, Ferrell B, Thorpe SW, and Randall RL
- Subjects
- Bone Neoplasms economics, Bone Neoplasms secondary, Follow-Up Studies, Humans, Incidence, Prognosis, Sex Factors, United States epidemiology, Bone Neoplasms epidemiology, Ethnicity statistics & numerical data, Health Status Disparities, Healthcare Disparities, Racial Groups statistics & numerical data, Social Class, Socioeconomic Factors
- Abstract
Background: We have analyzed sex, race/ethnicity or socioeconomic disparities in the incidence of metastatic bone disease (MBD)., Methods: Patients with the diagnosis of MBD at presentation for five most common primary anatomical sites was extracted from Surveillance, Epidemiology, and End Results Census tract-level dataset. Mean incidence of MBD for different sex, racial/ethnic and socioeconomic groups were compared., Results: The five most common anatomical sites with MBD at presentation include "lung: (n = 59 739), "prostate" (n = 19 732), "breast" (n = 16 244), "renal" (n = 7718) and "colon" (n = 3068). There was an increase in incidence of MBD among cancers originating from prostate (annual percentage change [APC] 4.94), renal (APC 2.55), and colon (APC 3.21) (p < 0.05 for all). Non-Hispanic Blacks had higher incidence of MBD for prostate and breast primary sites (p < 0.001). Non-Hispanic American Indian Alaskan Native had higher incidence of MBD for cancers originating from renal (p < 0.001) and colon (p = 0.049). A higher incidence of MBD was seen in lower socioeconomic status (SES) groups for the selected sites (p < 0.001)., Conclusions: These findings suggest that there are multiple sex-related, racial/ethnic and SES disparities in the incidence of MBD from the 5 most common primary sites. Higher incidence seen among lower SES suggests delay in diagnosis and limited access to screening modalities., (© 2021 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF